96402 Chemotherapy hormon antineopl square/intramuscular
Also known as: hormone chemo, hormonal therapy injection, endocrine chemo
Chemotherapy hormonal anti-neoplastic agent administration by subcutaneous or intramuscular injection.
In Plain Language
hormone cancer medicine shot
Clinical Context
Subcutaneous or intramuscular injection of hormonal chemotherapy agents used in hormone-sensitive cancers.
RVU Breakdown
| Work RVU | 0.19 |
| Total RVU | 0.19 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Billing & Documentation
Medicine section codes cover a wide range of non-surgical services. Documentation should include the clinical indication, procedure details, interpretation (if applicable), and any patient-specific findings.
How This Code Compares
With a work RVU of 0.19, this code ranks in the 11th percentile among Medicine codes — 4.1x below the median (0.78). The highest wRVU in this category is 23.92.
Specialties
Frequently Asked Questions
What is CPT code 96402?
CPT 96402 (Chemotherapy hormon antineopl square/intramuscular) is a Medicine code. Chemotherapy hormonal anti-neoplastic agent administration by subcutaneous or intramuscular injection.
Who uses CPT code 96402?
CPT 96402 is used by Oncology, Endocrinology. Subcutaneous or intramuscular injection of hormonal chemotherapy agents used in hormone-sensitive cancers.
When is CPT 96402 used?
Subcutaneous or intramuscular injection of hormonal chemotherapy agents used in hormone-sensitive cancers.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.